Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy.
Thielen N, Richter J, Baldauf M, Barbany G, Fioretos T, Giles F, Gjertsen BT, Hochhaus A, Schuurhuis GJ, Sopper S, Stenke L, Thunberg S, Wolf D, Ossenkoppele G, Porkka K, Janssen J, Mustjoki S. Thielen N, et al. Among authors: richter j. Clin Cancer Res. 2016 Aug 15;22(16):4030-8. doi: 10.1158/1078-0432.CCR-15-2791. Epub 2016 Mar 22. Clin Cancer Res. 2016. PMID: 27006491
Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage.
Järås M, Johnels P, Agerstam H, Lassen C, Rissler M, Edén P, Cammenga J, Olofsson T, Bjerrum OW, Richter J, Fan X, Fioretos T. Järås M, et al. Among authors: richter j. Exp Hematol. 2009 Mar;37(3):367-75. doi: 10.1016/j.exphem.2008.11.003. Epub 2009 Jan 9. Exp Hematol. 2009. PMID: 19135771 Free article.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM; ENESTnd Investigators. Saglio G, et al. N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525993 Free article. Clinical Trial.
Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
Agerstam H, Järås M, Andersson A, Johnels P, Hansen N, Lassen C, Rissler M, Gisselsson D, Olofsson T, Richter J, Fan X, Ehinger M, Fioretos T. Agerstam H, et al. Among authors: richter j. Blood. 2010 Sep 23;116(12):2103-11. doi: 10.1182/blood-2009-05-217182. Epub 2010 Jun 16. Blood. 2010. PMID: 20554971 Free article.
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
Järås M, Johnels P, Hansen N, Agerstam H, Tsapogas P, Rissler M, Lassen C, Olofsson T, Bjerrum OW, Richter J, Fioretos T. Järås M, et al. Among authors: richter j. Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16280-5. doi: 10.1073/pnas.1004408107. Epub 2010 Aug 30. Proc Natl Acad Sci U S A. 2010. PMID: 20805474 Free PMC article.
Second-generation BCR-ABL kinase inhibitors in CML.
Simonsson B, Porkka K, Richter J. Simonsson B, et al. Among authors: richter j. N Engl J Med. 2010 Oct 21;363(17):1673; author reply 1673-5. doi: 10.1056/NEJMc1007927. N Engl J Med. 2010. PMID: 20973145 No abstract available.
3,168 results